Kessler Foundation receives $725,000 grant for study to accelerate functional recovery in multiple sclerosis

Carly Wender, PhD, will focus on a novel approach to maximize learning and memory function in individuals with MS

2023-09-12

(Press-News.org) East Hanover, NJ – September 12, 2023 – Carly Wender, PhD, associate research scientist in the Center for Neuropsychology and Neuroscience Research at Kessler Foundation received a three-year $725,499 grant from the National Multiple Sclerosis Society for her study, “A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis.”

Cognitive impairment is a common symptom in individuals with multiple sclerosis (MS) that can be particularly burdensome. Specifically, impaired learning and memory can create challenges and barriers to functional independence, maintaining employment, and completing daily activities of living. “In particular, persons with MS who have advanced disease progression often have substantial mobility disability and greater learning and memory impairment,” explained Dr. Wender. “The co-occurrence of mobility disability and impaired cognition results in greater challenges in everyday life than either symptom alone.”

Most often, learning and memory deficits are caused by issues with acquiring new information as opposed to remembering previously learned information. “In the brain, deficits in new learning and memory are most likely tied to neurodegeneration/damage to the hippocampus, an important structure related to short- and long-term memory,” said Dr. Wender.

Unfortunately, common therapies prescribed for other MS-related symptoms, including disease modifying therapies, do not improve new learning and memory deficits. “One of the most effective treatments to improve new learning and memory deficits is a cognitive rehabilitation technique called “Kessler Foundation modified Story Memory Technique (KF-mSMT®).” However, the benefits of this cognitive rehabilitation technique have been specific to improving list-learning, which is only one aspect of new learning and memory,” stated Dr. Wender.

“Since the KF-mSMT treatment alone has not shown broad improvements in new learning and memory that translate to improvements in everyday life, we proposed a new, combinatory approach to treatment that combines KF-mSMT with innovative exercise training interventions to maximize improvements in new learning and memory and subsequently improve daily life,” explained Dr. Wender. This approach is entitled COMBINE: Combination Optimizes Memory Based on Imaging and Neuropsychological Endpoints.

“Exercise training has been linked to improvements in new learning and memory, most likely through changes in the hippocampus. We are seeking to challenge the brain more and lead to better neural communication and efficiency,” she added.

Study researchers aim to compare COMBINE to KF-mSMT alone on list-learning (specifically) and new learning and memory (globally). They hypothesize that COMBINE will outperform KF-mSMT alone in both areas. Additionally, they will assess the impact on hippocampal structure and function through magnetic resonance imaging, expecting COMBINE to yield greater improvements.

“We believe all participants will benefit to some degree, as they will all receive KF-mSMT treatment. However, participants taking part in the COMBINE intervention may show greater improvements that will better translate to new learning and memory in everyday life,” Dr. Wender explained. “If COMBINE proves to be beneficial for new learning and memory, it can serve as a blueprint for rehabilitation techniques for other impacted cognitive function,” she concluded

Funding: National Multiple Sclerosis Society grant # RFA-2301-40758

About the National Multiple Sclerosis Society
The National Multiple Sclerosis Society funds cutting-edge research, drives change through advocacy, facilitates professional education, collaborates with MS organizations around the world and provides services designed to help people with MS and their families move their lives forward. NMSS has invested more than $1.1 billion to advance MS research and paved the way for every effective MS treatment available today, including the first therapies for primary progressive and pediatric MS. For more information visit the National MS Society.

About Kessler Foundation
Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research. Our scientists seek to improve cognition, mobility, and long-term outcomes, including employment, for adults and children with neurological and developmental disabilities of the brain and spinal cord including traumatic brain injury, spinal cord injury, stroke, multiple sclerosis, and autism. Kessler Foundation also leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org.

Press Contacts at Kessler Foundation:
Deborah Hauss, DHauss@kesslerfoundation.org
Carolann Murphy, CMurphy@KesslerFoundation.org

Stay Connected with Kessler Foundation
Twitter | Facebook | YouTube | Instagram | SoundCloud

END

[Attachments] See images for this press release:

Kessler Foundation receives $725,000 grant for study to accelerate functional recovery in multiple sclerosis 2

ELSE PRESS RELEASES FROM THIS DATE:

Older adults with digestive diseases experience higher rates of loneliness, depression

2023-09-12

While life expectancy rates for older Americans are rising, nearly 40% of adults report living with a digestive disease of some kind. “Many people don’t realize that these conditions are very common in ambulatory care,” said Michigan Medicine gastroenterologist Shirley Ann Cohen-Mekelburg, M.D., who specializes in conditions like inflammatory bowel disease, Crohn’s disease and ulcerative colitis. “Ultimately, this creates an excess in health care spending in the United States. Not only are these conditions debilitating for the millions of people living with them, ...

Mount Sinai receives NIH grant to develop vaccines that can protect against many different types of coronaviruses

2023-09-12

The National Institute of Allergy and Infectious Diseases has awarded the Icahn School of Medicine at Mount Sinai a five-year, $13 million grant to bring together experts from multiple disciplines across five research institutions to create better vaccines against current as well as emerging coronaviruses. The COVID-19 pandemic, caused by severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), has infected 280 million people and caused more than five million deaths worldwide since late 2019. While considerable progress has been made to develop interventions (i.e., monoclonal antibodies, antivirals, vaccines) to treat and prevent COVID-19, ...

Setting the gold standard in diagnosis of lupus nephritis

2023-09-12

In the ever-perilous autoimmune disease world of systemic lupus erythematosus (SLE or lupus), up to 60% of adult patients and 80% of children will develop lupus nephritis (LN), and up to half of those will move on to end-stage renal disease. LN occurs when the immune system wrongly attacks the kidneys, preventing them from doing their job, i.e., cleaning blood, balancing body fluids and controlling hormones that impact blood pressure. Unfortunately, the most precise way to diagnose LN hasn’t been ...

Contributions to white matter injury in Alzheimer’s disease

2023-09-12

“The molecular mechanisms that mediate enhanced dysfunction of white matter parenchymal arterioles when vascular dysfunction and ADNC coincide remain elusive.” BUFFALO, NY- September 12, 2023 – A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 16, entitled, “Microvascular contributions to white matter injury in Alzheimer’s disease.” In their new editorial, researchers Zsolt Bagi, ...

Accelerating knowledge exchange in biodiversity genomics and bioinformatics

2023-09-12

Since its inception in 2021, the African BioGenome Project (AfricaBP), has made significant gains towards its ambitious goal of sequencing 100,000 endemic African species within the next 10 years. Recently, AfricaBP reported the successful implementation of the Open Institute in the journal Nature Biotechnology (https://rdcu.be/dlXYT), a pioneering biodiversity genomics and bioinformatics knowledge exchange programme. The AfricaBP Open Institute’s framework will establish openly accessible workshops across Africa, crafted in close collaborations with local African Institutions. ...

Call: "Journalist in Residence“ program at Institute of Science and Technology Austria (ISTA)

2023-09-12

The Institute of Science and Technology Austria (ISTA) is offering science journalists the opportunity for a paid three-month "Journalist in Residence“ program starting in April 2024. Applications are open until Oct. 31, 2023. The Institute of Science and Technology Austria (ISTA) in Klosterneuburg – in the immediate vicinity of Vienna – is a Ph.D.-granting research institute. Opened in 2009, the Institute is dedicated to basic research in the natural sciences, mathematics and computer sciences. It has a total of 1000 employees and 75 different research ...

COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complications

2023-09-12

An article published in NPJ Aging, a Springer Nature journal, reveals that natural production of auto-antibodies increases with age and that infection by SARS-CoV-2 can exacerbate production of auto-antibodies relating to auto-immune diseases, helping to explain why aging increases the chances of developing severe COVID-19. The study also discovered some of the factors that associate the severe form of the disease with blood clotting disorders such as thrombosis. “These findings open the door to a better ...

Alzheimer’s: An M.D./Ph.D. graduate student’s request for Yuhua Song as mentor leads to two NIH R01 awards totaling $5 million

2023-09-12

BIRMINGHAM, Ala. – In the summer of 2018, graduate student Hunter Dean from the Medical Scientist Training Program came to Yuhua Song, Ph.D., with a research idea. He wanted to pursue his doctoral research at the University of Alabama at Birmingham in Alzheimer’s disease — under the joint mentorship of Song, who had never worked in Alzheimer’s, and Erik Roberson, M.D., Ph.D., an Alzheimer’s expert in the UAB Department of Neurology and the Center for Neurodegeneration and Experimental Therapeutics, or CNET. That collaboration brought Song, a professor in the UAB Department of ...

Recommendations for addressing health-related social needs in cancer care introduced at NCCN Policy Summit

2023-09-12

Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—presented new recommendations for screening and addressing health-related social needs (HRSN) in people with cancer during a policy summit in Washington, D.C. The event included a keynote address from Ellen Lukens, Deputy Administrator and Director, The Center for Medicare and Medicaid Innovation (CMMI), and other speakers representing a diverse group of patient advocates, providers, and policymakers. The new recommendations for measuring and addressing HRSNs were ...

West Health-Gallup Poll: 70% of Americans uncomfortable with prospect of being admitted to nursing home

2023-09-12

WASHINGTON, D.C. — September 12, 2023 — More than 40% of Americans say nursing homes are unsafe and 7 in 10 say they would be uncomfortable ever having to be admitted to one even if they needed such care, while more than six in 10 (61%) feel similarly anxious about the prospect of admitting family members, according to the latest survey from West Health and Gallup. Safety was a particular area of perceived concern; 41% of respondents say nursing homes are not safe, 26% say they are, and about a third say they don’t know. Notably, the survey found that people over 35 were much ...